Concepedia

Publication | Open Access

Curcumin as adjuvant therapy to improve remission in myeloma patients: A pilot randomized clinical trial.

26

Citations

22

References

2022

Year

Abstract

Curcumin has an efficacy in improving overall remission and decreasing NF-κB, VEGF, TNF-α, and IL-6 levels in myeloma patients<b>.</b>

References

YearCitations

Page 1